Debt-to-equity of 10x Genomics, Inc. from 30 Jun 2020 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's debt by its shareholder equity.
- Summary
-
10x Genomics, Inc. quarterly Debt-to-equity in x history and change rate from 30 Jun 2020 to 31 Dec 2025.
- 10x Genomics, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 0.29x, a 0.39% increase year-over-year.
Debt-to-equity, Quarterly (x)
Debt-to-equity, YoY Quarterly Change (%)
10x Genomics, Inc. Quarterly Debt-to-equity (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 0.29x | +0x | +0.39% | 31 Dec 2025 |
| Q3 2025 | 0.29x | -0.01x | -1.7% | 30 Sep 2025 |
| Q2 2025 | 0.28x | -0x | -0.7% | 30 Jun 2025 |
| Q1 2025 | 0.29x | +0.01x | +4.4% | 31 Mar 2025 |
| Q4 2024 | 0.29x | +0.02x | +6.9% | 31 Dec 2024 |
| Q3 2024 | 0.29x | +0.03x | +10% | 30 Sep 2024 |
| Q2 2024 | 0.29x | +0.02x | +6.6% | 30 Jun 2024 |
| Q1 2024 | 0.28x | +0x | +0.13% | 31 Mar 2024 |
| Q4 2023 | 0.27x | +0x | +0.17% | 31 Dec 2023 |
| Q3 2023 | 0.27x | +0x | +0.96% | 30 Sep 2023 |
| Q2 2023 | 0.27x | +0.02x | +6.7% | 30 Jun 2023 |
| Q1 2023 | 0.28x | +0.03x | +13% | 31 Mar 2023 |
| Q4 2022 | 0.27x | +0.02x | +8.6% | 31 Dec 2022 |
| Q3 2022 | 0.26x | +0.01x | +4.3% | 30 Sep 2022 |
| Q2 2022 | 0.25x | -0.01x | -2.9% | 30 Jun 2022 |
| Q1 2022 | 0.24x | -0.05x | -18% | 31 Mar 2022 |
| Q4 2021 | 0.25x | -0.09x | -26% | 31 Dec 2021 |
| Q3 2021 | 0.25x | -0.14x | -35% | 30 Sep 2021 |
| Q2 2021 | 0.26x | -0.19x | -42% | 30 Jun 2021 |
| Q1 2021 | 0.3x | 31 Mar 2021 | ||
| Q4 2020 | 0.34x | 31 Dec 2020 | ||
| Q3 2020 | 0.39x | 30 Sep 2020 | ||
| Q2 2020 | 0.44x | 30 Jun 2020 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.